Disease | hypogonadism |
Symptom | C0242350|erectile dysfunction |
Sentences | 8 |
PubMedID- 20976267 | Testosterone products are used in the treatment of hypogonadism, which is associated with decreased libido, erectile dysfunction, reduced muscle mass, and reduced bone density . |
PubMedID- 23734517 | Association of erectile dysfunction with hypogonadism and metabolic syndrome among men of various age groups. |
PubMedID- 20626606 | hypogonadism was associated with erectile dysfunction. |
PubMedID- 20814778 | Andrology deals with male infertility, erectile dysfunction, loss of libido, ejaculatory disorders, hypogonadism, delayed puberty, male contraception, gynecomastia and aspects of the aging male. |
PubMedID- 24047635 | Conclusions: the treatment of erectile dysfunction associated with late start hypogonadism follows the same steps tha other generic cases of erectile dysfunction. |
PubMedID- 19798059 | hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses. |
PubMedID- 20967981 | Thus, combined treatment of erectile dysfunction in patients with hypogonadism (parenteral testosterone undecanoate and vardenafil) is more effective than monotherapy with androgen-containing drugs or inhibitors of phosphodiesterase of type 5. |
PubMedID- 24159331 | A constellation of symptoms known as late-onset hypogonadism characterized with sexual dysfunction (erectile dysfunction and loss of libido), deterioration of cognitive functions (decreased intellectual capacity, depressive mood changes, irritability, and loss of concentration), sleep disorders, loss of muscle mass and strength, increase in visceral fatty tissue, hair loss, skin changes, decrease in bone mineral density, osteopenia, and increase in development of fractures is seen in aging males . |
Page: 1